Cellular Biomedicine Group (CBMG) Announces Publication Titled “Target cell killing effects of CD20 targeting chimeric antigen receptor T cells derived from the type II anti-CD20 antibody” in Conjunction with 2017 ASCO Annual Meeting
May 19, 2017 08:28 ET
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., May 19, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...
Daniel Cascardo Launches an "Art, Action, Experience" Web Site to Showcase Personal Style and Gallery of Work
February 01, 2010 09:05 ET
|
Daniel Cascardo
DETROIT, MI--(Marketwire - February 1, 2010) - Challenging the viewer to be inspired and use
their imagination is the goal of Daniel Cascardo, a nationally recognized
visual artist and Michigan...